EF-009

N/A

Report date: 2024/11/21 13:51:08
NME

Base Information

Drug NameEF-009
Drug Alias NameEF-009
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEverfront Biotech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesEverfront Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsPancreatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A